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Introduction
Janus kinase 3 (JAK3), a tyrosine kinase, is mainly expressed in hematopoietic cells [1, 2] . JAK3 expressing cells include dendritic cells (DCs) [3] , antigen-presenting cells contributing to initiation and regulation of antigen-specific T-cell responses [4, 5] . JAK3 is involved in the signaling of cytokine receptors in hematopoietic cells [6] [7] [8] [9] [10] . The kinase contributes to the stimulation of cell proliferation as well as the inhibition of apoptosis [11] [12] [13] [14] [15] . The gain of function mutation A572V JAK3 was found in acute megakaryoplastic leukemia [16, 17] . Whether this mutation impacts on Ca 2+ signaling, remained elusive. Gene targeted mice lacking JAK3 suffer from several disorders affecting immune system and hematopoesis including impaired B cell development [18] . Jak3 deficiency further interferes with T cell activation leading to decreased IL-2 secretion [18] . In JAK3 deficient mice spleen, peripheral lymph nodes, and thymus are hypoplastic, and intestinal Peyer's patches completely lacking [18] . Jak3-deficiency leads to increased formation of 1,25(OH) 2 D 3 in the kidney [19] and to enhanced release of IL-12 [20] , which is produced by several cell types including dendritic cells [21] .
The function of DCs is governed by alterations of cytosolic Ca 2+ concentration ([Ca   2+ ] i ) [22] . [Ca 2+ ] i is increased following Ca 2+ release from intracellular stores accomplished by the IP3 receptor [23] . The emptying of the intracellular stores is followed by activation of Ca 2+ release activated current I crac [24] leading to store operated Ca 2+ entry (SOCE) [25] [26] [27] [28] , which is accomplished by the pore forming Ca 2+ channel subunits Orai1, Orai2 or Orai3 [29] [30] [31] [32] [33] and their regulators STIM1 or STIM2 [34] [35] [36] [37] [38] 
Materials and Methods

Mice
All animal experiments were conducted according to the German law for the welfare of animals and were approved by the authorities of the state of Baden-Württemberg. Experiments were performed with dendritic cells from 7-12 weeks old female and male gene-targeted mice lacking functional JAK3 (jak3 [27] . Bone marrow derived cells were flushed out of the cavities from the femur and tibia with PBS. Cells were then washed twice with RPMI and seeded out at a density of 2 x 10 6 cells/10ml per 60-mm dish. Cells were cultured for 8 days in RPMI 1640 (GIBCO, Carlsbad) containing: 10% FCS, 1% penicillin/streptomycin, 1% non-essential amino acids (NEAA) and 0.05% β-mercaptoethanol. Cultures were supplemented with GM-CSF (35 ng/ml, Immunotools) and fed with fresh medium containing GM-CSF on days 3 and 6. Experiments were performed on DCs at day 7-9 after isolation. ] i ) [49, 50] . To this end, the cells were loaded with Fura-2/AM (2 µM, Molecular Probes, Goettingen, Germany) for 15 min at 37 °C. Fluorescence measurements were carried out with an inverted phase-contrast microscope (Axiovert 100, Zeiss, Oberkochen, Germany). Cells were excited alternatively at 340 or 380 nm and the light was deflected by a dichroic mirror into either the objective (Fluar 40×/1.30 oil, Zeiss, Oberkochen, Germany) or a camera (Proxitronic, Bensheim, Germany). Emitted fluorescence intensity was recorded at 505 nm and data acquisition was accomplished by using specialized computer software (Metafluor, Universal Imaging, Downingtown, USA). The corresponding ratios (F 340 /F 380 ) were used to obtain intracellular Ca 
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; S f = instrumental constant). As a measure for the increase of cytosolic Ca 2+ activity, the slope and peak of the changes in the intracellular Ca 2+ ratio were calculated for each experiment.
Intracellular Ca 2+ was measured prior to and following addition of MgATP (100 μmol/l, Alfa Aesar GmbH & Co KG, Germany) or CXCL12 (300 ng/ml, Sigma, Germany). Store operated Ca 2+ entry (SOCE) was determined by extracellular Ca 2+ removal and subsequent Ca 2+ readdition in the presence of sarcoendoplasmatic reticulum Ca 2+ -ATPase (SERCA) inhibitor thapsigargin (1 µM, Invitrogen) [51] . For quantification of Ca For calibration purposes ionomycin (10 µM, Sigma-Aldrich, Taufkirchen, Germany) was applied at the end of each experiment.
Whole-cell patch clamp
Patch clamp experiments were performed at room temperature in voltage clamp, fast-wholecell mode according [52] [53] [54] . The currents were recorded by an EPC-9 amplifier (Heka, Lambrecht, Germany) using Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, N.Y., USA). For I CRAC measurements whole-cell currents were elicited by 200 ms square wave voltage pulses from -50 to +50 mV in 10 mV steps delivered from a holding potential of -30 mV. Alternatively, the currents were recorded with 200 ms voltage ramps from -50 to +50 mV. Leak currents determined as the currents at the very beginning of each experiment immediately after reaching the whole-cell mode were subtracted. The currents were recorded with an acquisition frequency of 10 kHz and 3 kHz low-pass filtered. DCs were superfused with a bath solution containing (in mmol/l): 140 NaCl, 5 KCl, 10 CaCl 2 , 20 glucose, 10 HEPES/ NaOH, pH 7.4. The patch clamp pipettes were filled with an internal solution containing (in mmol/l): 120 CsCl, 35 NaCl, 10 EGTA, 10 HEPES/CsOH, 0.04 inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 , Enzo Life Sciences), pH 7.4. The liquid junction potential ΔE between the CsCl-based pipette and the NaCl-based bath solutions was estimated according to Barry and Lynch [55] and approached 1 mV. The data were not corrected for ΔE. , the Fura-2 fluorescence ratio was similar in jak3 -/-DCs (1.01 ± 0.02; n = 76) and jak3 +/+ DCs (1.08 ± 0.02; n = 76).
Reduced ATP induced Ca
2+ release in jak3 -/-DCs In order to define the impact of JAK3 on agonist induced Ca 2+ release from intracellular stores, the effect of purinergic receptor agonist ATP in the absence of extracellular Ca 2+ was tested. As illustrated in Fig.1 , addition of ATP (100 µM) in the absence of extracellular Ca
2+
was followed by transient increase of Fura-2 fluorescence ratio reflecting Ca 2+ release from intracellular stores. Amplitude (peak, ∆ ratio), and velocity (slope, ∆ ratio/s), were both significantly less pronounced in jak3 -/-than in jak3 +/+ DCs (Fig.1) . Accordingly, lack of JAK3 compromises ATP induced intracellular Ca 2+ release. Cellular Physiology and Biochemistry presence of thapsigargin was followed by a sustained increase of Fura-2 fluorescence ratio reflecting SOCE, an effect again significantly less pronounced in jak3 -/-than in jak3 +/+ DCs (Fig. 2) . Lack of JAK3 thus impairs intracellular Ca 2+ release and SOCE. (300 ng/ml) was added to the bath solution leading to increase of Fura-2 fluorescence ratio. The amplitude (peak) and the velocity (slope, calculated from the linear fit) of the increase were analysed. B,C. Arithmetic means (± SEM, n = 80-94 cells) of the slope (B) and the peak (C) of the change in Fura-2 fluorescence ratio in jak3 +/+ (white bars) and jak3 -/-(black bars) DCs following addition of CXCL12 (300 ng/ml). **(p<0.01), *** (p<0.001) indicate significant difference between jak3 -/-and jak3 +/+ DCs, unpaired t-test. 2+ entry following activation of the chemokine receptor CXCR4, the effect of its ligand CXCL12 was tested. As shown in Fig.3 , the administration of CXCL12 (300 ng/ml) in the presence of extracellular Ca 2+ was followed by a sustained increase of Fura-2 fluorescence ratio reflecting receptor operated Ca 2+ entry (Fig.3) . The effect was again significantly less pronounced in jak3 -/-than in jak3 +/+ DCs (Fig.  3) . Accordingly, lack of JAK3 compromises CXCL12 induced Ca 2+ entry. (Fig. 5F -J) to jak3 +/+ DCs. As illustrated in Fig. 5F -J, a 24 h and 10 min pretreatment with WHI-P154 (22 µM) blunted significantly both the thapsigargin induced increase of Fura-2 fluorescence ratio reflecting Ca 2+ release and the increase of Fura-2 fluorescence ratio following readdition of Ca 2+ in the continued presence of thapsigargin reflecting SOCE. Accordingly, WHI-P154 mimics the effect of genetic JAK3 knockout on both, intracellular Ca 2+ release and SOCE. [56] [57] [58] [59] [60] , which directs the DCs to cytokines [61] , diverse antigens, including Toll-like receptor ligands, intact bacteria, and microbial toxins [5] . Ca 2+ -sensitive signaling plays a critical role in several further functions of DCs, including DC activation, maturation, and formation of immunological synapses with T cells. Moreover, alterations of cytosolic Ca 2+ trigger immune suppression or switch off of DC activity [22] . Ca 2+ signaling is further decisive for cell proliferation [62] [63] [64] [65] . The impact of JAK3 on cell proliferation is illustrated by the gain of function mutation A572V JAK3 apparently leading to acute megakaryoplastic leukemia [16, 17] . The impact of JAK3 deficiency on cell proliferation is, however, less obvious, as conflicting results have been reported on development and abundance of DCs in jak3 -/-mice. The in vitro development of jak3 -/-DCs is seemingly normal [20, 66] . In jak3 -/-mice normal [66] or decreased [20] abundance of splenic DCs, normal [20] or impaired [66] maturation and normal [66] or enhanced [20] DCs survival have been reported.
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In conclusion, lack of JAK3 has a profound influence on Ca 2+ signaling in DCs, i.e. downregulation of Ca 2+ release from intracellular stores, of receptor and store operated Ca 2+ entry, CRAC channel current, and of Na + /Ca 2+ exchanger activity.
